Gsk (GSK) Cash from Operations (2009 - 2026)
Gsk's Cash from Operations came in at $5.71 billion for the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Cash from Operations (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 8, 2026, Gsk reported Cash from Operations of $5.82 billion; for the year ended Dec 31, 2025, it came in at $11.79 billion, up 17.3% from the prior year.
- Cash from Operations carries a five-year compound annual growth rate of 6.9% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash from Operations was $10.05 billion in the year ended Dec 31, 2024 (-0.2%), $10.07 billion in the year ended Dec 31, 2023 (+2.4%), $9.83 billion in the year ended Dec 31, 2022 (-22.7%) and $12.72 billion in the year ended Dec 31, 2021 (+50.3%).
- The figure for the quarter ended Sep 8, 2026 represents the highest quarterly Cash from Operations since the quarter ended Dec 31, 2023.
- The fastest year-over-year change in Cash from Operations over five years came in the quarter ended Mar 31, 2022 (growth of 409.0%), and the weakest in the quarter ended Mar 31, 2023 (a decline of 89.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 10.69 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 8.62 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.44 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 5.37 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 5.88 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.87 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 4.00 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 3.57 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 835.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | -3.35 Bn |
| Mar 31, 2025 | 1.64 Bn |
| Dec 31, 2024 | 3.32 Bn |
| Mar 31, 2024 | 1.43 Bn |
| Dec 31, 2023 | 10.05 Bn |
| Mar 31, 2023 | 348.85 Mn |
| Dec 31, 2022 | 9.32 Bn |
| Mar 31, 2022 | 2.96 Bn |
| Dec 31, 2021 | 9.77 Bn |
| Mar 31, 2021 | 456.42 Mn |
| Dec 31, 2020 | 4.08 Bn |
| Mar 31, 2020 | 1.24 Bn |
| Dec 31, 2019 | 4.44 Bn |
| Sep 30, 2019 | 3.10 Bn |
| Mar 31, 2019 | 863.14 Mn |
| Dec 31, 2018 | 5.30 Bn |
| Mar 31, 2018 | 1.20 Bn |
| Dec 31, 2017 | 10.96 Bn |
| Sep 30, 2017 | 2.48 Bn |
API Access
Gsk Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();